Parkville Cancer Clinical Trials Unit

Coordinating cancer clinical trials across the Parkville Precinct

The Parkville Cancer Clinical Trials Unit (PCCTU) is Australia’s largest cancer clinical trials unit, specialising in first in human, phase I, medical oncology, haematology, and palliative care clinical trials.

In August 2016, the Parkville Cancer Clinical Trials Unit (PCCTU) amalgamated the cancer clinical trials units of Peter MacCallum Cancer Centre, The Royal Melbourne Hospital and The Royal Women’s Hospital. The PCCTU is located in the purpose built Victorian Comprehensive Cancer Centre building in Parkville, Melbourne.

PCCTU Profile

PCCTU Provides

Internationally recognised Investigators with expertise and experience in:

The conduct of cancer clinical trials
Basic research, translational research and biomarker development
Collaborations with national and international Investigators
Novel clinical trial design

Ten multi-disciplinary research teams based on tumour stream.

A dedicated clinical trial treatment area and facilities.

PCCTU Services

Strategically located, PCCTU delivers a precinct service with premier results. This provides access to a comprehensive range of specialised medical services, for example:

Shared pathology service
Clinical trials pharmacy
Imaging
Ophthalmology
Intensive Care Unit
Shared medical record
Speciality clinics
Translational expertise and leading edge laboratory service

Sponsoring a Clinical Trial with PCCTU

To approach PCCTU with a potential clinical trial, email through:

Mutual Confidentiality Agreement in editable word format (if required)
Protocol or synopsis
Timelines
Number of sites
Number of participants

To the Feasibility Coordinator and Tumour Stream lead per below stream profiles.

Feasibility Coordinator

Business hours, Monday to Friday
Email [email protected]
Phone +61 3 8559 7350 or +61 3 8559 7958

PCCTU site profile is available through the Shared Investigator Platform (SIP).

Early Drug Development / Phase One Program

The Early Drug Development (EDD) / Phase One team specialises in complex and first in human clinical trials, run by dedicated investigators and research staff with early drug development experience and expertise.

Early Drug Development Lead

A/Prof Jayesh Desai
[email protected]

Haematology Stream

Clinical Haematology is a unified department formed between Peter Mac and the Royal Melbourne Hospital and is the largest haematology service in the country, offering a broad clinical trials program.

The Clinical Haematology program offers a wide range of advanced research treatments for many of the Peter Mac and Royal Melbourne patients.

Haematology Leads

Medical Oncology Stream

The Medical Oncology tumour streams delivers world-class cancer care, backed by an uncompromising commitment to research, clinical trials and evidence-based practice to ensure the best possible outcome for patients.